side effects glp 1 receptor agonists The expanding role of GLP-1 agonists: a narrative review of current evidence and future directions Glucagon-like Receptor-1 agonists for obesity:

The short version: GLP-1 reduces how much you eat

Heres what obesity medicine physicians have to say

Until those results are in, the recommendation is extrapolated from non-pharmacologic weight-loss literature plus 2024-2025 case reports of GLP-1 patients who lifted and held their lean mass [11]

Strength training can help preserve muscle mass during treatment and prevent weight regain after stopping the medication

However, make sure you still aim to rotate injection sites regularly

In all SURPASS programs, tirzepatide demonstrated a much greater HbA1c-lowering impact than placebo or active comparators, such as basal insulin and GLP1RAs [83, 86]